Immediate Impact
62 standout
Citing Papers
Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity
2024 Standout
Renal cell carcinoma
2024 Standout
Works of Tom Ferguson being referenced
Pembrolizumab as post nephrectomy adjuvant therapy for patients with renal cell carcinoma: Results from 30-month follow-up of KEYNOTE-564.
2022
A phase I/II trial of sorafenib and infliximab in advanced renal cell carcinoma
2010
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Tom Ferguson | 68 | 61 | 44 | 48 | 17 | 152 | |
| Christian Leiber | 47 | 89 | 43 | 75 | 20 | 225 | |
| Xiaochen Ma | 61 | 31 | 30 | 48 | 23 | 152 | |
| Silvia Chiellino | 98 | 60 | 26 | 58 | 16 | 195 | |
| Qingya Yang | 23 | 63 | 22 | 54 | 19 | 141 | |
| Evangelos Xynos | 57 | 30 | 98 | 50 | 15 | 194 | |
| Lisa M.C. van Hoogstraten | 53 | 34 | 120 | 53 | 12 | 193 | |
| Daniela Purcea | 39 | 63 | 29 | 83 | 15 | 232 | |
| Stephanie The | 69 | 38 | 29 | 61 | 15 | 198 | |
| Shiliang Tu | 69 | 38 | 29 | 62 | 20 | 156 | |
| Łukasz Durko | 116 | 19 | 66 | 58 | 17 | 213 |
All Works
Loading papers...